This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.
Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.
It’s been years since AI proponents started promising big returns on healthcare providers’ investments in the technology. The results have yet to catch up with the pitches. What’s the holdup?
SCAI celebrated cardiologists William W. O'Neill, MD, and Cindy L. Grines, MD, for the important roles they played in the development of primary PCI. “It was challenging,” Grines explained. “We had the pharmaceutical industry that was anti-primary angioplasty and we had a lot of our own colleagues that were anti-primary angioplasty."
Self-expanding and balloon-expandable TAVR valves are associated with comparable success rates and one-year outcomes when treating type 1 bicuspid aortic stenosis. However, each valve type comes with its own advantages and disadvantages.
The report, developed by Abbott, examined everything from AI to social determinants of health. One key finding was that patients grade their overall satisfaction with a physician or hospital based on much more than the effectiveness of their treatment.
Hospitals and health systems have been facing financial pressures, with many experiencing negative operating margins. Workforce pressures in 2022, including staffing shortages and higher costs, have impacted the bottom line.
The program, UnitedHealthcare Rewards, encourages eligible members to use a compatible activity tracker, smartwatch or smartphone to meet daily activity goals, track sleep and measure other health goals.
“HHS is using every tool available to us to lower healthcare costs and increase access to high-quality, affordable healthcare,” says HHS Secretary Xavier Becerra.
"This transaction reflects our mission to become the leading musculoskeletal technology company in the world by developing products that promote healing in patients with musculoskeletal disorders," said Dan Scavilla, president and CEO of Globus Medical.